DIRAS3 and ovarian carcinoma: Studies demonstrate that in ovarian cancer microenvironments [40], DIRAS3-dependent autophagy sustains dormant cancer cell viability under nutrient deprivation, suggesting its involvement in therapy resistance through metabolic adaptation.